EMERYVILLE, Calif., May 03, 2018 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. This sustainable and cost-effective version of Firmenich’s iconic Z11 molecule was developed using Amyris’s disruptive proprietary technology to develop a reliable and sustainable supply of an intermediate, using a fermentation-based production process, for which Firmenich has then applied its state of the art, proprietary green chemistry.
“We are pleased with our ability to support Firmenich’s product innovation as they continue to be a leader in developing game-changing ingredients for their customers,” said John Melo, President & CEO of Amyris. “Amyris has collaborated with Firmenich since 2010, successfully growing a palette of bio-based fragrance ingredients and intermediates as Firmenich continues their legacy of providing the finest ingredients well into the future, with the added benefit of being derived from a sustainable resource.”
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]


GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Middle East Conflict Impacts Australia and New Zealand Businesses
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours 



